Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2025 07:55 ET | Source: HCW Biologics Inc.

HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements

MIRAMAR, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...
May 15, 2025 18:14 ET | Source: HCW Biologics Inc.

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing...
May 13, 2025 20:01 ET | Source: HCW Biologics Inc.

HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

$5 million offering by HCW Biologics Inc. funded by Armistice Capital
December 23, 2024 08:10 ET | Source: HCW Biologics, Inc

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Mandatory press release to disclose receipt of Nasdaq Staff Determination Letter.
November 18, 2024 07:00 ET | Source: HCW Biologics, Inc

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

HCW Biologics signed license agreement with WY Biotech
November 14, 2024 16:40 ET | Source: HCW Biologics, Inc

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

Press release for Q3 2024 business highlights and financial results
May 15, 2024 16:39 ET | Source: HCW Biologics, Inc

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

Earning release for Q1 2024
April 01, 2024 16:10 ET | Source: HCW Biologics, Inc

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

Q4 and Year End Earnings Release and Business Highlights
June 14, 2023 07:30 ET | Source: HCW Biologics, Inc

HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders

MIRAMAR, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...